Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ABTL-0812 by Ability Pharmaceuticals for Metastatic Pancreatic Cancer: Likelihood of Approval
ABTL-0812 is under clinical development by Ability Pharmaceuticals and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData,...
Data Insights
ABTL-0812 by Ability Pharmaceuticals for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
ABTL-0812 is under clinical development by Ability Pharmaceuticals and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...